AZD0328 explained

AZD0328 is an experimental drug. It is a selective α7 nicotinic receptor agonist that enhances cortical dopamine release and improves learning and attentional processes in rats.^[1]

Notes and References

1. Sydserff S, Sutton EJ, Song D, Quirk MC, Maciag C, Li C, Jonak G, Gurley D, Gordon JC, Christian EP, Doherty JJ, Hudzik T, Johnson E, Mrzljak L, Piser T, Smagin GN, Wang Y, Widzowski D, Smith JS . 6 . Selective alpha7 nicotinic receptor activation by AZD0328 enhances cortical dopamine release and improves learning and attentional processes . Biochemical Pharmacology . 78 . 7 . 880–8 . October 2009 . 19615981 . 10.1016/j.bcp.2009.07.005 .